A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 28, 2013

Primary Completion Date

September 15, 2014

Study Completion Date

September 15, 2014

Conditions
Renal Anemia Associated With Chronic Renal Failure (CRF)
Interventions
DRUG

roxadustat

oral

DRUG

darbepoetin alfa

iv

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokuriku

Kansai

Kanto

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY